Efficacy and Safety of Pimecrolimus Cream 1% in Patients (2 to 11 Years Old) With Mild to Moderate Facial Atopic Dermatitis

NCT00130364 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
200
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Novartis